Clinical Evaluation of the Diagnostic Role of MicroRNA-155 in Breast Cancer

Table 3

The demographic characteristics of study subjects as per study groups.

Groups	Control group frequency (%)	Cancer group frequency (%)
Menarche
<13	9 (25)	13 (36.1)	0.306
≥13	27 (75)	23 (61.9)
Abortion
Yes	17 (47.2)	15 (41.7)	0.635
No	19 (52.8)	21 (58.3)
Contraceptive drugs
Yes	14 (38.9)	17 (47.2)	0.475
No	22 (61.1)	19 (48.7)